NCT/Study#
NA /
MOLECULAR-PROFILING-SAMPLING
Molecular profiling in patients with advanced lung or thymic cancer previously treated with immune checkpoint inhibitor therapy.
DISEASE GROUP:
Phase 1 (Thoracic)
current phase:
NA
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
